1. Farhadi Z, Alidoost S, Behzadifar M, Mohammadibakhsh R, Khodadadi N, Sepehrian R, al. The prevalence of migraine in Iran: A systematic review and meta-analysis. Iran Red Crescent Med J. 2016; 18(10):e40061. [DOI:10.5812/ircmj.40061] [
DOI:10.5812/ircmj.40061]
2. Miri A, Nasiri M, Zonoori S, Yarahmad F, Dabbagh-Moghadam A, Askari G, et al. The association between obesity and migraine in a population of Iranian adults: A case-control study. Diabetes Metab Syndr: Clin Res Rev. 2018; 12(5):733-6. [DOI:10.1016/j.dsx.2018.04.020] [
DOI:10.1016/j.dsx.2018.04.020]
3. Rainero I, Govone F, Gai A, Vacca A, Rubino E. Is migraine primarily a metaboloendocrine disorder. Curr Pain Headache Rep. 2018; 22(5):36. [DOI:10.1007/s11916-018-0691-7] [
DOI:10.1007/s11916-018-0691-7]
4. Hossain MA, Hakim M, Hasan M, Rahman MA, Rashid M, Sagir G, et al. Socio-demographic and comorbidity profiles of migraine patients in a headache clinic of a tertiary care hospital in Dhaka City. J Natl Inst Neurosci Bangladesh. 2017; 3(1):48-51. [DOI:10.3329/jninb.v3i1.36272] [
DOI:10.3329/jninb.v3i1.36272]
5. Woldeamanuel Y, Cowan R. Worldwide migraine epidemiology: Systematic review and meta-analysis of 302 community-based studies involving 6,216,995 participants. Neurol. 2016; 86(Suppl 16):P6-100. [DOI:10.1016/j.jns.2016.11.071] [
DOI:10.1016/j.jns.2016.11.071]
6. Bhoi SK, Kalita J, Misra UK. Metabolic syndrome and insulin resistance in migraine. J Headache Pain. 2012; 13(4):321-6. [DOI:10.1007/s10194-012-0416-y] [
DOI:10.1007/s10194-012-0416-y]
7. Guldiken B, Guldiken S, Taskiran B, Koc G, Turgut N, Kabayel L, et al. Migraine in metabolic syndrome. Neurologist. 2009; 15(2):55-8. [DOI:10.1097/NRL.0b013e31817781b6] [
DOI:10.1097/NRL.0b013e31817781b6]
8. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol, Neurosurg Psychiatry. 2010; 81(4):428-32. [DOI:10.1136/jnnp.2009.192492] [
DOI:10.1136/jnnp.2009.192492]
9. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine The GEM population-based study. Neurol. 2005; 64(4):614-20. [DOI:10.1212/01.WNL.0000151857.43225.49] [
DOI:10.1212/01.WNL.0000151857.43225.49]
10. Rainero I, Limone P, Ferrero M, Valfrè W, Pelissetto C, Rubino E, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia. 2005; 25(8):593-7. [DOI:10.1111/j.1468-2982.2005.00928.x] [
DOI:10.1111/j.1468-2982.2005.00928.x]
11. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine a population study. Neurol. 2006; 66(4):545-50. [DOI:10.1212/01.wnl.0000197218.05284.82] [
DOI:10.1212/01.wnl.0000197218.05284.82]
12. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA. Headache prevalence related to diabetes mellitus: The Head-HUNT study. Eur J Neurol. 2007; 14(7):738-44. [DOI:10.1111/j.1468-1331.2007.01765.x] [
DOI:10.1111/j.1468-1331.2007.01765.x]
13. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008; 49(7):571-6. [PMID] [
PMID]
14. Azizi F, Rahmani M, Emami H, Mirmiran PA, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002; 47(6):408-26. [PMID] [
DOI:10.1007/s000380200008] [
PMID]
15. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetol. 2003; 46(9):1190-8. [DOI:10.1007/s00125-003-1167-8] [PMID] [
DOI:10.1007/s00125-003-1167-8]
16. Haghdoost AA, Rezazadeh Kermani M, Sadghirad B, Baradaran HR. Prevalence of type 2 diabetes in the Islamic Republic of Iran: Systematic review and meta-analysis. East Mediterr Health J. 2009; 15(3):591-9. [PMID] [
DOI:10.26719/2009.15.3.591] [
PMID]
17. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA. 2006; 296(3):283-91. [DOI:10.1001./jama.296.3.283] [
DOI:10.1001/jama.296.3.283] [
PMID]
18. Sillanpää M, Aro H. Headache in teenagers: Comorbidity and prognosis. Funct Neurol. 2000; 15(Suppl 3):116-21. [PMID] [
PMID]
19. Burch RC, Rist PM, Winter AC, Buring JE, Pradhan AD, Loder EW, et al. Migraine and risk of incident diabetes in women: A prospective study. Cephalalgia. 2012; 32(13):991-7. [DOI:10.1177/0333102412453954] [PMID] [
DOI:10.1177/0333102412453954]
20. Berge LI, Riise T, Fasmer OB, Hundal Ø, Oedegaard KJ, Midthjell K, et al. Does diabetes have a protective effect on migraine. Epidemiol. 2013; 24(1):129-34. [DOI:10.1097/EDE.0b013e31827623d0] [
DOI:10.1097/EDE.0b013e31827623d0]
21. Melmed S. Williams textbook of endocrinology. Amsterdam: Elsevier Health Sciences; 2016.
22. Ghayeghran AR, Dehnadi Moghadam A, Sedighi Moghadam P. [Survey of Teachers' Knowledge about Migraine in Rasht in 2005 (Persian)]. J Guilan Univ Med Sci. 2007; 16(61):51-9.
23. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, et al. Headache, cerebrovascular symptoms, and stroke The Atherosclerosis Risk in Communities Study. Neurol. 2005; 64(9):1573-7. [DOI:10.1212/01.WNL.0000158326.31368.0] [PMID] [
DOI:10.1212/01.WNL.0000158326.31368.04] [
PMID]
24. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: A prospective cohort study. Cephalalgia. 2007; 27(4):368-71. [DOI:10.1111/j.1468-2982.2007.01298.x] [PMID] [
DOI:10.1111/j.1468-2982.2007.01298.x]
25. Rosamond W. Are migraine and coronary heart disease associated? An epidemiologic review. Headache: J Head Face Pain. 2004; 44:S5-12. [DOI:10.1111/j.1526-4610.2004.04103.x] [
DOI:10.1111/j.1526-4610.2004.04103.x]